MINNEAPOLIS, May 31, 2024 /PRNewswire/ Bio-Techne Corporation today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor.
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
MINNEAPOLIS, May 22, 2024 /PRNewswire/ Bio-Techne Corporation and Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines.
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2024. Third Quarter FY2024.
/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and.